Found 9 matching trials
Study to Evaluate the Efficacy of HepaStem in Urea Cycle Disorders Paediatric Patients (HEP002)
PHASE2The aim of the study is to assess the efficacy of HepaStem treatment in pae...
Location
Cliniques Universitaires Saint-Luc
Phase II Safety Study of 2 Dose Regimens of HepaStem in Patients With ACLF
PHASE2The study will assess the safety of different dose regimens of HepaStem in ...
Safety and Tolerability of HepaStem in Patients With Cirrhotic and Pre-cirrhotic NASH Patients
PHASE1Multicenter, open-label, safety and tolerability study of ascending doses o...
Safety Study of HepaStem for the Treatment of Urea Cycle Disorders (UCD) and Crigler-Najjar Syndrome (CN)
PHASE1The purpose of this study is to assess the safety and to appraise the effic...
Location
Saint Luc University Hospital
HepaStem Long-Term Safety Registry
N/AAll patients having received at least one infusion of the Investigational M...
Effect of Liver MSCs in Blood of Patients With Liver Disease.
N/ALiver MSCs or Adult Derived Human Liver Stem/progenitor Cells (ADHLSCs) inf...
Location
Cliniques Universitaires Saint-Luc
Long-term Safety Follow-up Study of Patients Having Received HepaStem (SAF001)
N/AThe purpose of this study is to assess the long-term safety follow-up of pa...
Location
Promethera Biosciences
A Safety and Efficacy Study of Infusions of HepaStem in Urea Cycle Disorders Pediatric Patients
PHASE2This is a phase2, prospective, open label study designed to investigate the...
Location
Samsung Medical Center
Study to Evaluate the Efficacy and Safety of HepaStem in Patients With Acute on Chronic Liver Failure (ACLF)
PHASE2This is an interventional, double blind, randomized (2:1), and placebo-cont...
Location
Medical University Of Vienna